I am a surgical pathologist at Memorial Sloan Kettering Cancer Center. I work closely with clinical colleagues (pathologists, surgeons, medical oncologists, and other physicians) in diagnosing and managing patients with gynecologic diseases. By examining tissue samples obtained from patients following surgery or biopsy and by selecting appropriate additional (e.g. molecular genetic) tests, I diagnose tumors and other diseases, and determine their likely clinical behavior. This information helps guide treatment decisions.
My research activities involve studies of the genetics, biology and pathology of gynecologic cancers, melanoma, prostate cancer, and familial cancers. Over the past decade, in conjunction with clinicians and laboratory scientists, I have published over 180 articles, book chapters and abstracts, and have presented scientific works at several international conferences.
As the Pathology Group Leader in the Center for Molecular Oncology, I oversee and consult on pathology-related issues pertaining to research studies performed in the Center. The Center is responsible for carrying out cutting-edge molecular genetic studies of a broad spectrum of cancer types in collaboration with clinical and scientific colleagues at Memorial Sloan Kettering Cancer Center.
My goals are to continue to work with clinical colleagues to deliver the best care for patients, and to make key discoveries with research collaborators that will further our understanding of cancers and ultimately result in improved outcomes for cancer patients.
- Clinical Expertise: Anatomic Pathology; Gynecologic Pathology; Melanocytic tumors; Molecular Pathology
- Languages Spoken: English
- Education: The University of Sydney (Australia); Royal College of Pathologists of Australasia (Australia)
- Residencies: Westmead Hospital (Australia); Liverpool Hospital (Australia)
- Fellowships: Westmead Hospital (Australia)
- Board Certifications: Anatomical Pathology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more